Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
A microbiological analysis of 102 patients suffering from cystic fibrosis was conducted over a 22 month period. 20 microbial species with the following incidence were identified: Pseudomonas aeruginosa: 83.4%; Candida albicans: 29.4%; Staphylococcus aureus: 24.5%; Staphylococcus epidermidis: 11.8%; Haemophilus influenzae: 11.8%; Streptococcus pneumoniae; 6.9%; Pseudomonas maltophilia: 6.8%; Aspergillus fumigatus: 5.9%. Other species were present in less than 5% of the patients. In the majority of specimens with P. aeruginosa, more than one type (up to six) was detectable. These strains were identical in colony appearance, O-serotype and pyocin-type. Quantitative analysis revealed concentrations of colony-forming units of 10(7) to 10(9) for P. aeruginosa, 10(6) to 10(8) for P. maltophilia, 10(4) to 10(7) for S. aureus, 10(4) to 10(6) for S. epidermidis and 10(4) to 10(7) for C. albicans in the majority of specimens. Significant differences were observed in the time periods during which the pathogens persisted in the patients. Maximum persistence was observed for P. aeruginosa. P. maltophilia and A. fumigatus had about similar persistence rates, which were lower than those for P. aeruginosa but above those for S. aureus and H. influenzae. S. epidermidis was eliminated within shorter periods than S. aureus. C. albicans, although the second most frequent microorganism identified, showed a very low persistence rate. The microbiological analysis confirms results from other research centers (high incidence of P. aeruginosa), but reveals significant regional differences as well (Pseudomonas cepacia not detectable, higher incidence of P. maltophilia and C. albicans). This underlines the necessity for detailed qualitative and quantitative microbiological analysis of sputa from cystic fibrosis patients as a prerequisite for rational analysis of etiological, epidemiological and therapeutical aspects of cystic fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An example of this is the acidification of an environment through acid production (such as lactate) by bacteria such as Staphylococcus aureus, a frequent co-isolate with C. albicans from patients' lungs with cystic fibrosis (CF) as well as Streptococci (Bauernfeind et al., 1987; Friedman et al., 2006; Chotirmall et al., 2010).”
From Iron at the Centre of Candida albicans Interactions (2018) · cites this paper as Bauernfeind et al., 1987
Citations
Cites
Manual of Clinical Microbiology
Blair, J. E., Lennette, E. H., & Truant, J. P. (1970) · Postgraduate Medical Journal · doi:10.1136/pgmj.46.542.733-c · Cited by 2,642
Identification of Enterobacteriaceae.
Edwards, P. R., & Ewing, W. H. (1972) · Andalas University Repository (Andalas University) · Cited by 2,038
Pseudomonas cepacia infection in cystic fibrosis: An emerging problem
Isles, A., Maclusky, I., Corey, M., Gold, R., Prober, C., Fleming, P., & Levison, H. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80993-2 · Cited by 846
Allergic bronchopulmonary aspergillosis in cystic fibrosis
Laufer, P., Fink, J. N., Bruns, W. T., Unger, G. F., Kalbfleisch, J. H., Greenberger, P. A., & Patterson, R. (1984) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(84)90482-2 · Cited by 278
Identification of enterobacteriaceae
Balows, A. (1987) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(87)90124-6 · Cited by 243
MICROBIOLOGY OF LUNG INFECTIONS IN CYSTIC FIBROSIS PATIENTS
HØIBY, N. (1982) · Acta Paediatrica · doi:10.1111/j.1651-2227.1982.tb09640.x · Cited by 226
Aspergillosis and atopy in cystic fibrosis.
Nelson, L. A., Callerame, M., & Schwartz, R. H. (1979) · PubMed · doi:10.1164/arrd.1979.120.4.863 · Cited by 205
A simple test system for the separation of staphylococci from micrococci
Schleifer, K. H., & Kloos, W. E. (1975) · Journal of Clinical Microbiology · doi:10.1128/jcm.1.3.337-338.1975 · Cited by 176
Pseudomonas aeruginosa : clinical manifestations of infection and current therapy
Doggett, R. G., & Aduan, R. P. (1979) · Academic Press eBooks · Cited by 157
Forstner, G. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90777-2 · Cited by 147
Research works printed but not linked: 1
- Govan, J. B. Pseudomonas aeruginosa and respiratory infection in cystic fibrosis. Cystic Fibrosis News. Focus on Research: Number 48 (1983) 5–9.
Cited by
Items 101–149 of 149
Mossman, A. K., Svishchuk, J., Waddell, B. J. M., Izydorczyk, C., Buckley, P. T., Hilliard, J. J., Al-Ghalith, G., Zheng, L., Lynch, A. S., Mody, C. H., et al. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202108-965oc · Cited by 10
Bauernfeind, A., Rotter, K., & Weisslein-Pfister, C. (1987) · Infection · doi:10.1007/bf01644138 · Cited by 9
“In contrast, only minor attention has been paid to microorganisms which are detectable less regularly in cystic fibrosis sputa (1).”
BackgroundSelf-citationExploring Oxylipins in Host–Microbe Interactions and Their Impact on Infection and Immunity
Neff, R. J., & Radka, C. D. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47030190 · Cited by 10
“Staphylococcus aureus , a Gram-positive bacterium commonly associated with skin infections and a frequent co-colonizer with C. albicans in cystic fibrosis patients [108,109], also exploits oxylipins to modulate immune responses.”
Cross, A. R., Csatary, E. E., Raghuram, V., Diggle, F. L., Whiteley, M., Wuest, W. M., & Goldberg, J. B. (2020) · Microbiology · doi:10.1099/mic.0.000923 · Cited by 8
Fibrosis quística: estudio microbiológico durante un período de 8 años
Marcellés, A. F., Moreira, P. B., Codina, G., Pérez, F. F., Barroso, N. C., & Cortés, S. L. (1995) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(15)30845-0 · Cited by 8
Ballestero, S., Villaverde, R., Escobar, H., & Baquero, F. (1992) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01961145 · Cited by 8
“Intralumenal cultures should be restricted to specific types of catheters in which hub colonisation is prevalent ( 2 ) or used for investigatory purposes.”
BackgroundMethodSolimani, P., Salari, S., Khalizadeh, S., Hassanzad, M., Khodavaisy, S., Abastabar, M., hajiaghaei, H. F., & Badali, H. (2014) · Research in Molecular Medicine · doi:10.18869/acadpub.rmm.2.3.23 · Cited by 7
Long Persistence of a Streptococcus pneumoniae 23F Clone in a Cystic Fibrosis Patient
Rieger, M., Mauch, H., & Hakenbeck, R. (2017) · mSphere · doi:10.1128/msphere.00201-17 · Cited by 7
Moore, J. E., Shaw, A., Howard, J. L., Dooley, J. S. G., & Elborn, J. S. (2004) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-3-8 · Cited by 7
Moore, J. E., Xu, J., Millar, B. C., Courtney, J., & Elborn, J. S. (2003) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2003.01956.x · Cited by 7
“1999) and these have demonstrated that bacterial loading of CF sputum is in the order 10(7)–10(9) colony forming units (CFU) per gram of sputum (Bauernfeind et al. 1987) and that the proportion of individual pathogens may vary, depending on the microbial ecology present.”
BackgroundPSEUDOMONAS AND RELATED GENERA
Brady, M. T. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50140-0 · Cited by 8
Fungi-bacterium interactions: Helycobacter pyroli - Candida albicans.
Palencia, S. L., Lagos, G., & García, A. (2016) · Journal of Science with Technological Applications · doi:10.34294/j.jsta.16.1.5 · Cited by 8
“Este tipo de agrupaciones se encuentran en una variedad de ambientes muy diversos tales como los pulmones de pacientes con fibrosis quística, la cavidad oral humana, quesos, vinos, ambientes agrícolas y bosques [3-7].”
Fungal Colonization in Patients with Cystic Fibrosis
Kargar, M. L., Fooladi-Rad, S., Davoudi, M. M., Khalilzadeh, S., Hassanzad, M., Mayahi, S., Khodavaisy, S., & Badali, H. (2013) · Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences · Cited by 5
Gourari-Bouzouina, K., Boucherit‐Otmani, Z., Seghir, A., Tani, Z. Z. B. A., Bendoukha, I., Benahmed, A., Aissaoui, M., & Boucherit, K. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116321 · Cited by 7
Treatment of infections in patients with cystic fibrosis
Marks, M. I. (1987) · Infection · doi:10.1007/bf01647727 · Cited by 5
“With the use of this monitoring and others such as exercise tolerance, frequency of pulmonary exacerbations and quantitative microbiology (5), enthusiasm is increasing for the use of controlled therapeutic trials for the examination of aerosol antibiotics in these patients.”
MethodPolyguluronate simulations shed light onto the therapeutic action of OligoG CF-5/20
Hills, O. J., Yong, C. W., Scott, A. J., Smith, J., & Chappell, H. F. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116945 · Cited by 4
Initial characteristics of cystic fibrosis in Algeria: Description of 34 pediatric cases
Bendoukha, I., Boucherit‐Otmani, Z., Tani, Z. Z. B. A., Seghir, A., Madouni, M., Radoui, A., & Boucherit, K. (2024) · Pediatric Pulmonology · doi:10.1002/ppul.26939 · Cited by 5
“23 Pseudomonas aeruginosa was detected in 34.3% of airway cultures, and those patients were treated with a dual IV antibiotic regimen of Amikacin and Ceftazidime.”
MethodInfluentialPolymicrobial Biofilms in Cystic Fibrosis Lung Infections: Effects on Antimicrobial Susceptibility
Galdino, A. C. M., Vaillancourt, M., Celedonio, D., & Jorth, P. A. (2022) · Springer series on biofilms · doi:10.1007/978-3-031-15349-5_7 · Cited by 5
Marks-Austin, K. A., Fiel, S. B., Campbell, P. W., & Stull, T. L. (1995) · Seminars in Pediatric Infectious Diseases · doi:10.1016/s1045-1870(05)80045-7 · Cited by 4
Deconstructing the chronic wound
Widgerow, A. D. (2009) · Cited by 3
Imaging Mass Spectrometry, Metabolism, and New Views of the Microbial World
Hoefler, B. C., & Straight, P. D. (2014) · Wiley eBooks · doi:10.1002/9781118876015.ch10 · Cited by 6
Hsieh, Y.-Y. P., O’Keefe, I. P., Wang, Z., Sun, W., Yang, H., Vu, L. M., Smalley, N. E., Ernst, R. K., Dandekar, A. A., & Malik, H. S. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003673 · Cited by 5
“P. aeruginosa coexists with the fungal pathogen Candida albicans in urinary tracts, chronic wounds, and the airways of people with cystic fibrosis [33–36].”
Hills, O. J., Poskrobko, Z., Scott, A. J., Smith, J., & Chappell, H. F. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287191 · Cited by 2
Cugini, C., Kolter, R., & Hogan, D. A. (2014) · ASM Press eBooks · doi:10.1128/9781555815578.ch26 · Cited by 2
Taylor, P. C., McLaws, M., de Borde, M., & Pritchard, R. C. (2004) · Pathology · doi:10.1080/00313020410001721636 · Cited by 2
“Laboratories that do not regularly receive sputa from CF patients and scientists who do not have contact with physicians who manage CF patients may not recognise the need to examine sputa for all of these pathogens.(12) This retrospective analysis of responses from laboratories participating in the RCPA QAP between 19…”
BackgroundMukoviszidose (Zystische Fibrose)
App, E. M. (2002) · Springer eBooks · doi:10.1007/978-3-662-08120-4_16 · Cited by 1
Comments on bacterial and fungal interactions in medicine, agriculture and the environment
Chrysanthus, C. S. (2017) · International Journal of Advanced Research in Biological Sciences (IJARBS) · doi:10.22192/ijarbs.2017.04.08.002 · Cited by 1
(2017) · Pediatric Pulmonology · doi:10.1002/ppul.23839 · Cited by 1
Bacteriologia da Fibrose Cística
Lutz, L., de Paris, F., Vieira, M. I., Marques, E. A., & Barth, A. L. (2011) · Americanae (AECID Library) · Cited by 8
Fortkamp, D. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.11.2018.tde-17072018-184806 · Cited by 3
Widespread fungal-bacterial competition for magnesium enhances antibiotic resistancePreprint
Hsieh, Y.-Y. P., Sun, W. W., Young, J. M., Cheung, R., Hogan, D. A., Dandekar, A. A., & Malik, H. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.25.563990 · Cited by 1
The State of Cystic Fibrosis in Turkey
Demirkol, M., Erturan, Z., Hüner, G., Baykal, T., Kurdoğlu, G., & Anğ, Ö. (1996) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7359-8_15
Implications of Biofilm Formation in Chronic Wounds and in Cystic Fibrosis
Shunmugaperumal, T. (2010) · Wiley eBooks · doi:10.1002/9780470640463.ch8
PrecipitatingPseudomonas aeruginosa antibodies and antimicrobial therapy in cystic fibrosis patients
Trancassini, M., Vito, D. D., Cimino, G. G., Antonelli, M., Quattrucci, S., & Cipriani, P. (1996) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01695663
“In most patients persistent colonization with Pseudomonas aeruginosa leads to a poor prognosis because of the organism's antibiotic resistance and ability to adapt to many environmental conditions (2).”
BackgroundPlace des apports oraux en acides gras oméga-3 dans la mucoviscidose
Panchaud, A., Kernen, Y., & Roulet, M. (2006) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2005.12.006 · Cited by 1
Bacterial colonization of the respiratory tract in patients with cystic fibrosis
Renders, N. H. M. (2000) · EUR Research Repository (Erasmus University Rotterdam)
Libertucci, J. (2013) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/26019
Gonzaga, L., & Gonzole, R. (2002)
Bakteriologie, V. L., & Heesemann, J. (2004)
Clinical Implications of Interkingdom Fungal and Bacterial Biofilms
Ramage, G., O’Donnell, L. E., Kean, R., Townsend, E. R., & Rajendran, R. (2017) · CRC Press eBooks · doi:10.4324/9781315120119-2 · Cited by 1
Genetic Regulation of Mucoidy in Pseudomonas aeruginosa
Withers, T. R. (2013)
Aebi, C., Bauernfeind, A., Döring, G., Przyklenk, B., Schneider, I., & Schöni, M. H. (2001) · Springer eBooks · doi:10.1007/978-3-642-56796-4_3 · Cited by 2
Self-citationApp, E. M., Bals, R., Behr, J., Döring, G., Griese, M., Lindemann, H., Schuster, A., & Vogelmeier, C. F. (2001) · Springer eBooks · doi:10.1007/978-3-642-56796-4_4
Unity in Diversity: Interkingdom Polymicrobial Biofilms in Disease
Varahan, S. (2022) · Springer series on biofilms · doi:10.1007/978-3-031-15349-5_9
Magnesium depletion unleashes two unusual modes of colistin resistance with different fitness costsPreprint
Hsieh, Y.-Y. P., O’Keefe, I. P., Wang, Z., Sun, W., Yang, H., Vu, L. M., Ernst, R. K., Dandekar, A. A., & Malik, H. S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.15.618514
“P. aeruginosa coexists with the fungal pathogen Candida albicans in urinary tracts, chronic wounds, and the airways of people with cystic fibrosis [33-36].”
Viral, Fungal and Atypical Bacterial Infections in Cystic Fibrosis
Przyklenk, B., & Bauernfeind, A. (1996) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7359-8_1
Self-citation
Metadata
- Authors
- Bauernfeind, A., Hörl, G., Jungwirth, R., Petermüller, C., Przyklenk, B., Weisslein-Pfister, C., Bertele, R. M., & Harms, K.
- Affiliations
- Max-von-Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie (DE)
- Ludwig-Maximilians-Universität München (DE)
- ORCID
- Hörl, G.
- Venue
- Infection
- Published
- 1987-07
- Volume
- 15
- Issue
- 4
- Pages
- 270-277
- ISSN
- 0300-8126 (ISSN-L)
- 1439-0973
- OpenAlex
- W85901280
- Cited by
- 150
- References
- 31
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 6 · 2017: 7 · 2016: 5 · 2015: 5 · 2014: 7 · 2013: 6 · 2012: 2
- FWCI
- 5.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Infection (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Keywords
- cystic fibrosis, sputum microbiology, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Candida albicans, Staphylococcus aureus, Staphylococcus epidermidis, Haemophilus influenzae, Aspergillus fumigatus, bacterial persistence, bacterial co-infection
- MeSH terms
- Adolescent, Adult, Bacteria, Child, Child, Preschool, Cystic Fibrosis, Mitosporic Fungi, Female, Haemophilus influenzae, Humans, Male, Pseudomonas, Pseudomonas aeruginosa, Sputum, Staphylococcus, Streptococcus pneumoniae
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.